Question 1

What specific benefits does Ganfort® provide for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea clinical trial (NCT01976624). Contact the study team or your healthcare provider for specific answers.

Question 2

Are there any known side effects of using Ganfort® that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea clinical trial (NCT01976624). Contact the study team or your healthcare provider for specific answers.

Question 3

How does Ganfort® compare to other treatments for glaucoma or ocular hypertension?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea clinical trial (NCT01976624). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I do if I experience any problems while using Ganfort®?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea clinical trial (NCT01976624). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to use Ganfort® to see its full effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea clinical trial (NCT01976624). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there ongoing support or monitoring while I use this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea clinical trial (NCT01976624). Contact the study team or your healthcare provider for specific answers.

What this study is about